nootkatone has been researched along with malondialdehyde in 2 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 1 (50.00) | 24.3611 |
| 2020's | 1 (50.00) | 2.80 |
| Authors | Studies |
|---|---|
| Bi, K; Cheng, X; Jia, Y; Jing, H; Qi, Y; Wu, B; Xiao, F; Yan, T | 1 |
| He, B; Jia, Y; Li, F; Wu, B; Xiao, F; Xiong, W; Yan, T | 1 |
2 other study(ies) available for nootkatone and malondialdehyde
| Article | Year |
|---|---|
Combination of schisandrin and nootkatone exerts neuroprotective effect in Alzheimer's disease mice model.
Topics: Alzheimer Disease; Animals; Cyclooctanes; Disease Models, Animal; Glutathione; Lignans; Malondialdehyde; Maze Learning; Mice; Neuroprotective Agents; Oxidative Stress; Plant Extracts; Polycyclic Compounds; Polycyclic Sesquiterpenes; Superoxide Dismutase | 2019 |
Nootkatone improves anxiety- and depression-like behavior by targeting hyperammonemia-induced oxidative stress in D-galactosamine model of liver injury.
Topics: Ammonia; Animals; Antidepressive Agents; Antioxidants; Anxiety; Behavior, Animal; Brain; Cell Survival; Chemical and Drug Induced Liver Injury; Depression; Galactosamine; Hyperammonemia; Lipopolysaccharides; Liver; Male; Malondialdehyde; Mice; Oxidative Stress; PC12 Cells; Polycyclic Sesquiterpenes; Rats | 2021 |